| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17c27b3b10eebe077835589594378277 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
1979-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1985-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4446c31bbf80af96375e18c86b7ee0be |
| publicationDate |
1985-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4518579-A |
| titleOfInvention |
pH stabilized fluorescing ophthalmic composition containing fluorexon |
| abstract |
An ophthalmic composition for use in the human eye comprising an aqueous solution of fluorexon whose pH has been adjusted to between pH 5.4 and 6.2 to deliver maximum fluorescence and additionally containing sufficient buffer to maintain that pH even after instillation into the eye. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006128621-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10246819-B2 |
| priorityDate |
1979-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |